U.S. Diabetes Devices Market Size, Share and Growth Trends

0
4

Polaris Market Research releases its new research report on the U.S. diabetes devices market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive insight into how the market is likely to shape up in different market segments. Opportunities and challenges that can affect the market in the future have been discussed. Through both quantitative and qualitative analysis, this report helps market players understand the factors influencing the market and its future growth prospects.

U.S. Diabetes Devices Market at a Glance

Market Size, 2025

USD 28.57 billion

Market Size, 2034

USD 50.39 billion

CAGR, 2026–2034

6.5%

Largest Segment and Share, 2025

Continuous Glucose Monitoring Devices, 37.0% share

Fastest-Growing Segment and CAGR

Homecare (End-use), 5.6% CAGR

Leading Region and Share, 2025

Not applicable — U.S.-focused report

Fastest-Growing Region and CAGR

Not applicable — U.S.-focused report

 

Understanding the U.S. Diabetes Devices Market

The U.S. diabetes devices market encompasses products used in the management and treatment of diabetes, including blood glucose monitoring devices, continuous glucose monitoring (CGM) systems, insulin pumps, insulin pens, and related accessories. Rising diabetes prevalence, FDA approvals, and innovations in minimally invasive monitoring technology are driving adoption of these devices across hospitals, diagnostic centers, and homecare settings nationwide.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/us-diabetes-devices-market

What Are the Major Factors Influencing the Market?

The U.S. diabetes devices industry is influenced by several factors that impact the demand, implementation, investment, innovation, and competition in the market. This report discusses the key forces that drive market growth and those that may bring opportunities or restrict future development.

Key Growth Driver: Rising Prevalence of Pre-Diabetic and Diabetic Population Among U.S. Adults

Rising diabetes and pre-diabetes prevalence among U.S. adults is a central driver of the market. According to NIDDKD estimates, around 38.4 million people aged 18 and above in the U.S. were living with diabetes in 2021, representing 11.6% of the population, with rising obesity and sedentary lifestyles further contributing to increased diagnosis and device adoption.

Emerging Opportunity: Integration of Insulin Pumps with Automated Insulin Delivery Systems

The increasing focus on integrating insulin pumps with automated insulin delivery systems is creating substantial market opportunities. These systems adjust insulin dosing based on real-time glucose readings, reducing the management burden for patients and improving outcomes, a trend expected to accelerate as smart and minimally invasive devices gain wider adoption.

Market Trend: Growing Integration of AI and Smart Technology in Diabetes Devices

Diabetes device manufacturers are increasingly embedding AI and connected technology into monitoring and delivery devices, enabling real-time data interpretation, remote monitoring, and personalized lifestyle recommendations. This trend reflects the rapid adoption of smart, minimally invasive wearables that support continuous, real-time blood glucose management.

Key Challenge: Stringent Regulations for Approval of Diabetes Devices

Strict regulatory approval processes required to commercialize diabetes devices, aimed at eliminating safety risks, can slow the introduction of new reusable and more accurate technologies. Devices must meet accuracy and suitability requirements across all age groups and patient types before commercialization, which can extend development and launch timelines.

How Is AI Impacting the U.S. Diabetes Devices Market?

AI has become increasingly relevant in different industries; however, the impact of this technology largely depends on the particular industry. This report provides an analysis of the effects of artificial intelligence in the U.S. diabetes devices industry, analyzing those applications of artificial intelligence which are pertinent to the industry's products or services.

AI Impact Assessment: AI is useful in monitoring blood sugar levels in real time and providing straightforward interpretation to improve control. It is also effective in enhancing insulin devices by modifying doses according to real-time glucose levels, facilitates remote monitoring to make diabetes management possible from anywhere, and aids in identifying risk factors through health data patterns.

Which Market Segments Are Gaining Momentum?

The market is segmented by type, end-use, and distribution channel. Continuous glucose monitoring devices led the type segment with a 37.0% share in 2025, driven by rising diabetes cases and growing adoption of wearables for real-time glucose tracking. By end-use, hospitals held the largest share at 45.0%, supported by adoption of advanced diabetes technologies for patient care, while homecare is projected to grow fastest at a 5.6% CAGR as smart, minimally invasive devices gain traction for self-monitoring.

How Is the Competitive Landscape Changing?

The U.S. diabetes devices market is highly competitive, with both established and smaller players present. Companies across the sector are making significant investments to strengthen their technological capabilities and effectively manage diabetes care, supported by strategic partnerships and funding for next-generation device development.

Key players covered in the report include: Abbott Diabetes Care; B Braun Melsungen AG; BD; Biocorp; Johnson & Johnson; LifeScan Inc.; Medtronic PLC; Molex; Roche Diabetes Care; Senseonics, Inc.; and Tandem Diabetes Care, Inc.

Future Market Perspective

The U.S. diabetes devices will continue to grow steadily owing to the increasing prevalence of diabetes and growing popularity of CGM wearable technology. Artificial intelligence, analytics, and remote monitoring technology are expected to pave the way for new innovations, along with additional improvements in minimally invasive devices and smart technology through 2034.

More Trending Latest Reports By Polaris Market Research:

Industrial Enzymes Market

Colostrum Market

Sodium Hydroxide Market

Hospital Electronic Health Records Market

Colostrum Market

Dicyclopentadiene Polyesters Resin Market

Travel And Expense Management Software Market

Powder Coating Equipment Market

U.S. Ophthalmic Spectacle Lenses and Equipment Market

Pesquisar
Categorias
Leia Mais
Outro
Computer-Aided Manufacturing (CAM) Software Market: A Global Industry Overview
Computer-Aided Manufacturing Cam Software Market Overview The global Computer Aided...
Por harshtech 2026-08-29 06:06:13 0 85
Outro
Flame Retardant Market Size Expands With Advanced Electronics Applications
Fire safety is no longer limited to building codes or emergency systems. It is increasingly...
Por Rutujad 2026-09-04 06:06:25 0 128
Outro
Getting a Second Vet Opinion Singapore: A Clear Guide for Concerned Pet Owners
Understanding the Value of Another Veterinary Perspective When a pet receives a serious diagnosis...
Por iammarrycosta 2026-08-26 13:10:48 0 109
Art
Dr Oz Male Enhancement Pills™ US AU Reviews: Safety,
Hey there, health seekers! It’s a topic that just seems to pop up everywhere, doesn't it?...
Por NutrWellnessHub 2026-08-19 21:14:18 0 69
Outro
Frozen Food Manufacturers Focus on Premium and Healthy Offerings
The frozen food market is witnessing steady growth as consumers increasingly seek convenient,...
Por prasad03 2026-08-05 07:38:47 0 217
AC Mingle https://acmingle.com